Description

n-[(20S)-20-(Dimethylamino)-16α-Hydroxy-4β-Hydroxymethyl-4,14-Dimethyl-B(9A)-Homo-19-Nor-5α-Pregna-1(10),9(11)-Dien-3β-Yl]Benzamide is a high-purity, structurally complex steroid derivative with significant potential in advanced pharmaceutical research and development. This compound is valued for its unique molecular framework, which serves as a critical intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic agents. It is primarily sought after by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in developing next-generation steroid-based treatments.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel steroid-based drugs targeting hormonal regulation and metabolic pathways.
• Research Chemical: Used in academic and industrial R&D for studying steroid receptor interactions, structure-activity relationships (SAR), and metabolic pathways.
• Active Pharmaceutical Ingredient (API) Development: Serves as a core structure for developing new therapeutic agents in preclinical and clinical studies.
• Reference Standard: Employed as a high-purity analytical standard in quality control (QC) laboratories for method development and validation in pharmaceutical analysis.
• Biochemical Research: Utilized in biochemical assays to investigate enzyme inhibition, cell signaling, and other steroid-mediated biological processes.

Basic Information

Product Name	n-[(20S)-20-(Dimethylamino)-16α-Hydroxy-4β-Hydroxymethyl-4,14-Dimethyl-B(9A)-Homo-19-Nor-5α-Pregna-1(10),9(11)-Dien-3β-Yl]Benzamide
CAS No.	107259-41-6
Molecular Formula	C33H48N2O3
Molecular Weight	520.75 g/mol
Synonyms	Benzamide, N-[(20S)-20-(dimethylamino)-16α-hydroxy-4β-(hydroxymethyl)-4,14-dimethyl-B(9a)-homo-19-nor-5α-pregna-1(10),9(11)-dien-3β-yl]-; 107259-41-6; 16α-Hydroxy-4β-hydroxymethyl-4,14-dimethyl-B(9a)-homo-19-nor-5α-pregna-1(10),9(11)-dien-3β-yl 20S-dimethylaminobenzamide; (20S)-20-(Dimethylamino)-16α-hydroxy-4β-hydroxymethyl-4,14-dimethyl-B(9a)-homo-19-nor-5α-pregna-1(10),9(11)-dien-3β-yl benzamide.
EINECS	Contact for details

Quality Control

Our n-[(20S)-20-(Dimethylamino)-16α-Hydroxy-4β-Hydroxymethyl-4,14-Dimethyl-B(9A)-Homo-19-Nor-5α-Pregna-1(10),9(11)-Dien-3β-Yl]Benzamide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications and test results are provided and can be tailored to meet specific client or regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants or an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.